+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aquaculture Therapeutics Market by Therapeutic Type, Species, Application, Mode Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Aquaculture Therapeutics Market by Therapeutic Type, Species, Application, Mode Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Aquaculture Therapeutics Market by Therapeutic Type, Species, Application, Mode Of Administration, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305516
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Aquaculture Therapeutics Market grew from USD 2.74 billion in 2024 to USD 3.00 billion in 2025. It is expected to continue growing at a CAGR of 9.16%, reaching USD 4.64 billion by 2030.

Setting the Stage for Aquaculture Therapeutics Growth

The aquaculture therapeutics sector has emerged as a pivotal arena in the pursuit of global food security and sustainable marine farming practices. Driven by escalating demand for high-quality protein sources and increasing awareness of animal welfare, market participants are investing heavily in solutions that mitigate disease risk and enhance production efficiency. Advances in biology, chemistry, and digital monitoring tools have converged to create an environment ripe for innovation. Regulatory authorities worldwide are balancing the need to safeguard public health with the imperative to support industry growth, resulting in a dynamic compliance landscape that requires constant vigilance and strategic agility. As environmental concerns gain prominence, stakeholder expectations are evolving to demand safer, more targeted interventions that minimize ecological impact. This introduction sets the stage for a deep exploration of transformative market forces, the implications of new trade policies, and the segmentation insights that will guide investment and product development decisions for years to come.

Navigating Transformational Currents Reshaping Aquaculture Therapeutics

The aquaculture therapeutics landscape is undergoing a profound transformation driven by scientific breakthroughs, digital integration, and shifting regulatory frameworks. Precision delivery methods, such as targeted immersion systems and novel oral formulations, are redefining dosage accuracy and minimizing waste. At the same time, vaccine development has accelerated through recombinant DNA technology, enabling faster response to emerging pathogens. Data analytics platforms are empowering farmers with real-time health monitoring, predictive outbreak modeling, and supply chain transparency. Regulatory bodies have introduced stricter residue limits and environmental assessments, prompting manufacturers to innovate greener chemistries and biodegradable carriers. Partnerships between biotech firms and feed producers are giving rise to next-generation immunostimulants and probiotics that enhance fish microbiomes. These changes are not incremental; they represent a fundamental shift toward integrated, sustainable solutions that span the entire aquaculture value chain.

Assessing the 2025 U.S. Tariff Impact on Aquaculture Therapeutic Supplies

In 2025, the introduction of new U.S. tariffs on imported aquaculture therapeutics has reverberated across global supply chains, compelling stakeholders to reevaluate sourcing strategies and cost structures. Antimicrobials, vaccines, and feed additives previously imported under preferential trade terms now face increased duties, driving up landed costs and compressing margins. Domestic manufacturers are seizing the opportunity to expand production capacity, while international suppliers are exploring tariff mitigation tactics such as regionalized warehousing and local partnerships. End users have adjusted by optimizing inventory management and seeking bulk procurement agreements to buffer against price volatility. Furthermore, the tariff regime has accelerated discussions around nearshoring and the development of domestic API capabilities, as companies strive to reduce exposure to geopolitical uncertainties. These strategic shifts underscore the importance of resilience and adaptive planning in an environment where trade policies can alter market dynamics overnight.

Decoding Market Segmentation to Drive Targeted Therapeutic Strategies

An in‐depth review of market segmentation reveals distinct dynamics across therapeutic types, species, applications, administration modes, and distribution channels. Antibiotics remain a cornerstone of curative treatments, with broad spectrum variants commanding significant share while narrow spectrum alternatives gain traction for targeted pathogen control. Disinfectants are evolving beyond traditional chlorine formulations, as quaternary ammonium compounds offer improved stability and reduced environmental load. Immunostimulants such as beta glucan and herbal extracts are forging new pathways in enhancing innate immunity, and probiotic lines divided between bacterial and yeast strains are building on their capacity to balance gut flora. Vaccine portfolios encompass inactivated, live attenuated, and recombinant platforms, each presenting unique benefits in efficacy and production scalability. From the perspective of species, high‐value fish like salmon and tilapia drive innovation in preventive care, while carp and shrimp continue to rely on curative antibiotics. Mollusk health is seeing increased attention, particularly in oyster hatcheries, and prawn producers are integrating disinfectant protocols for biosecurity. Curative and preventive applications demand different logistical considerations, with immersion treatments favored for large‐scale biomass and injections reserved for high‐value broodstock. Oral delivery is gaining ground through encapsulation technologies that enhance stability. Distribution strategies range from direct sales agreements that deepen customer engagement to distributor partnerships that expand geographic reach, alongside the emergence of online channels facilitating rapid access for smaller operators.

Regional Dynamics Driving Aquaculture Therapeutic Adoption Worldwide

Regional markets exhibit unique growth trajectories shaped by regulatory environments, production systems, and consumer preferences. In the Americas, strong regulatory frameworks and investments in R&D have fostered innovation hubs, particularly in salmon farming regions. Latin American tilapia producers are adopting preventive vaccination campaigns to protect against bacterial outbreaks, while prawn farmers in Brazil are piloting probiotic blends to improve survival rates. Europe, Middle East and Africa present a complex mosaic of compliance standards and market maturity; Western European nations emphasize residue monitoring and vaccine certification, while emerging markets in Eastern Europe and North Africa are rapidly scaling capacity for commercial fish species. In Middle Eastern aquaculture zones, water scarcity concerns are accelerating interest in closed recirculating systems paired with advanced therapeutics. Asia-Pacific remains the largest contributor to global aquaculture output, led by China’s extensive carp operations, India’s shrimp production, and Southeast Asia’s tilapia and oyster farming. Policymakers across the region are incentivizing sustainable practices and domestic manufacturing of key therapeutics to reduce dependency on imports.

Profiling Leading Innovators in Aquaculture Therapeutics Sector

A survey of key industry players underscores a competitive landscape defined by strategic alliances, product diversification, and technology integration. Leading multinational animal health corporations are expanding their aquaculture portfolios through acquisitions of specialized vaccine developers and biotech ventures. Innovative biotech firms are forging collaborations with feed producers to co‐develop immunostimulant-fortified feeds, while smaller niche players are distinguishing themselves with proprietary probiotic strains and modular delivery systems. Several companies have announced pipeline products utilizing recombinant technology to target emerging viral threats, signaling a shift away from traditional whole-pathogen vaccines. Others are investing in digital health platforms that complement their therapeutic offerings, enabling end‐to‐end farm management solutions. The intensifying focus on sustainability is driving organizations to pursue certifications for eco‐friendly production, and to partner with environmental NGOs to validate the safety profiles of new chemistries. Across the board, strategic R&D investments and supply chain optimization initiatives are proving critical for maintaining market leadership.

Strategic Imperatives to Accelerate Market Leadership in Aquaculture Health

Industry stakeholders must take proactive measures to capitalize on emerging opportunities and mitigate evolving risks. First, embedding advanced analytics into disease monitoring workflows will enable real‐time decision making and early intervention, reducing reliance on broad‐spectrum antibiotics. Second, prioritizing the development of recombinant and novel vaccine platforms will position organizations ahead of regulatory mandates for residue limits and environmental impact. Third, building resilient supply chains through regional manufacturing partnerships and diversified sourcing will hedge against trade policy disruptions. Fourth, adopting sustainable chemistry frameworks and pursuing third‐party ecological certifications will enhance brand reputation and unlock premium market segments. Fifth, cultivating strategic alliances between biotech firms, feed producers, and digital health vendors will create integrated solutions that drive customer loyalty. Finally, tailoring product portfolios to high‐growth species and application segments will ensure resource allocation aligns with the shifting demand landscape.

Robust Methodology Underpinning Comprehensive Market Insights

This research employs a multi‐stage methodology designed to ensure accuracy, depth, and relevance. Primary data were collected through structured interviews with industry executives, aquaculture veterinarians, feed mill managers, and regulatory specialists. Secondary research incorporated peer‐reviewed journals, government publications, company financial reports, and patent databases. Data points from diverse sources were triangulated to validate trends, with statistical analyses applied to historical trade and production figures to identify inflection points. Market segmentation frameworks were refined through iterative expert feedback, ensuring alignment with real‐world usage patterns. All findings were subjected to rigorous quality control protocols, including cross‐verification by internal research teams and external academic advisors. Ethical guidelines were strictly observed throughout the process, guaranteeing transparency and impartiality in the presentation of insights.

Converging Insights to Bolster Aquaculture Therapeutics Success

The convergence of scientific innovation, shifting trade policies, and evolving regional dynamics presents both challenges and opportunities for stakeholders in the aquaculture therapeutics market. By understanding the nuanced segmentation of therapeutic types, species applications, delivery methods, and distribution channels, decision-makers can tailor strategies that align with specific growth drivers. Awareness of the 2025 tariff environment underscores the need for supply chain resilience, while regional insights highlight where to focus market development efforts. Leading companies are setting the pace through strategic R&D investments and ecosystem partnerships, offering a blueprint for emerging players. Ultimately, success will depend on the ability to integrate data-driven decision making with sustainable practices, ensuring that aquaculture continues to meet global demand in an environmentally responsible manner.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Therapeutic Type
    • Antibiotic
      • Broad Spectrum Antibiotic
      • Narrow Spectrum Antibiotic
    • Disinfectant
      • Chlorine
      • Quaternary Ammonium Compound
    • Immunostimulant
      • Beta Glucan
      • Herbal Extract
    • Probiotic
      • Bacterial Probiotic
      • Yeast Probiotic
    • Vaccine
      • Inactivated Vaccine
      • Live Attenuated Vaccine
      • Recombinant Vaccine
  • Species
    • Crustacean
      • Prawn
      • Shrimp
    • Fish
      • Carp
      • Salmon
      • Tilapia
    • Mollusk
      • Mussel
      • Oyster
  • Application
    • Curative
    • Preventive
  • Mode Of Administration
    • Immersion
    • Injection
    • Oral
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale SA
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • DSM Nutritional Products AG
  • Novozymes A/S
  • Chr. Hansen Holding A/S
  • Vetoquinol SA
  • Benchmark Holdings PLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aquaculture Therapeutics Market, by Therapeutic Type
8.1. Introduction
8.2. Antibiotic
8.2.1. Broad Spectrum Antibiotic
8.2.2. Narrow Spectrum Antibiotic
8.3. Disinfectant
8.3.1. Chlorine
8.3.2. Quaternary Ammonium Compound
8.4. Immunostimulant
8.4.1. Beta Glucan
8.4.2. Herbal Extract
8.5. Probiotic
8.5.1. Bacterial Probiotic
8.5.2. Yeast Probiotic
8.6. Vaccine
8.6.1. Inactivated Vaccine
8.6.2. Live Attenuated Vaccine
8.6.3. Recombinant Vaccine
9. Aquaculture Therapeutics Market, by Species
9.1. Introduction
9.2. Crustacean
9.2.1. Prawn
9.2.2. Shrimp
9.3. Fish
9.3.1. Carp
9.3.2. Salmon
9.3.3. Tilapia
9.4. Mollusk
9.4.1. Mussel
9.4.2. Oyster
10. Aquaculture Therapeutics Market, by Application
10.1. Introduction
10.2. Curative
10.3. Preventive
11. Aquaculture Therapeutics Market, by Mode Of Administration
11.1. Introduction
11.2. Immersion
11.3. Injection
11.4. Oral
12. Aquaculture Therapeutics Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online
13. Americas Aquaculture Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Aquaculture Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Aquaculture Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Zoetis Inc.
16.3.2. Elanco Animal Health Incorporated
16.3.3. Ceva Sante Animale SA
16.3.4. Merck & Co., Inc.
16.3.5. Phibro Animal Health Corporation
16.3.6. DSM Nutritional Products AG
16.3.7. Novozymes A/S
16.3.8. Chr. Hansen Holding A/S
16.3.9. Vetoquinol SA
16.3.10. Benchmark Holdings PLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AQUACULTURE THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. AQUACULTURE THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. AQUACULTURE THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AQUACULTURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AQUACULTURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AQUACULTURE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY BROAD SPECTRUM ANTIBIOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY NARROW SPECTRUM ANTIBIOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHLORINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY BETA GLUCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HERBAL EXTRACT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY BACTERIAL PROBIOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY YEAST PROBIOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRAWN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CARP, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SALMON, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TILAPIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MUSSEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OYSTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CURATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMERSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 83. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 84. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 85. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 86. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 87. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 88. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 89. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 90. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 91. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 96. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 97. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 98. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 99. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 101. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 102. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 103. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 104. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 162. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 163. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 164. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 165. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 166. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 167. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 168. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 169. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 170. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 175. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 176. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 177. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 178. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 180. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 181. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 182. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 183. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 200. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 201. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 202. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 203. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 204. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 205. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 206. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 207. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 208. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 209. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 214. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 215. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 216. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 217. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 218. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 219. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 220. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 221. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 222. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 265. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 266. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 267. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 268. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 269. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 270. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 271. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 272. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 273. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 274. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. DENMARK AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 291. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 292. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 293. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 294. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 295. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 296. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 297. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 298. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 299. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 300. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 302. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 304. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 305. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 306. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 307. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 308. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 309. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 310. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 311. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 312. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 313. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 315. FINLAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 317. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION

Companies Mentioned

The companies profiled in this Aquaculture Therapeutics market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale SA
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • DSM Nutritional Products AG
  • Novozymes A/S
  • Chr. Hansen Holding A/S
  • Vetoquinol SA
  • Benchmark Holdings PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.64 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Aquaculture Market Size, Share, Trends and Forecast 2025-2033 - Product Image

Aquaculture Market Size, Share, Trends and Forecast 2025-2033

  • Report
  • 139 Pages
  • Global
From
Integrated Recirculating Aquaculture System (RAS) Market Report 2025 - Product Image

Integrated Recirculating Aquaculture System (RAS) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aquaculture Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Aquaculture Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 110 Pages
  • Global
From
Aquaculture Equipment Market by Equipment Type, Farm Type, Water Type, Species, Application - Global Forecast to 2030 - Product Image

Aquaculture Equipment Market by Equipment Type, Farm Type, Water Type, Species, Application - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Aquaculture Products Market by Species, Culture System, Farming Environment, Application, Product Form - Global Forecast to 2030 - Product Image

Aquaculture Products Market by Species, Culture System, Farming Environment, Application, Product Form - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.